K
Kaname Miyamoto
Researcher at Eisai
Publications - 16
Citations - 422
Kaname Miyamoto is an academic researcher from Eisai. The author has contributed to research in topics: Tumor necrosis factor alpha & Substituent. The author has an hindex of 7, co-authored 16 publications receiving 412 citations.
Papers
More filters
Journal ArticleDOI
Involvement of tumor necrosis factor‐α in development of hepatic injury in galactosamine‐sensitized mice
Ieharu Hishinuma,Junichi Nagakawa,Kazuo Hirota,Kaname Miyamoto,Kazuo Tsukidate,Takashi Yamanaka,Kouichi Katayama,Isao Yamatsu +7 more
TL;DR: In this article, the authors showed that injection of lipopolysaccharide and D-galactosamine, at doses of 0.2 μg/kg and 800 mg/kg, respectively, elicited massive hepatic necrosis within 24 hr in C3H/HeN mice.
Journal ArticleDOI
Involvement of tumor necrosis factor-α in the pathogenesis of activated macrophage-mediated hepatitis in mice
Junichi Nagakawa,Ieharu Hishinuma,Kazuo Hirota,Kaname Miyamoto,Takashi Yamanaka,Kazuo Tsukidate,Kouichi Katayama,Isao Yamatsu +7 more
TL;DR: Pretreatment with dexamethasone or 16,16-dimethyl-prostaglandin E2 attenuated not only the elevation of plasma tumor necrosis factor-alpha activity but also the increase in plasma aminotransferase activity and improved the survival rate.
Journal ArticleDOI
Suppression of Murine Endotoxin Response by E5531, a Novel Synthetic Lipid A Antagonist
Seiichi Kobayashi,Tsutomu Kawata,Akifumi Kimura,Kaname Miyamoto,Koichi Katayama,Isao Yamatsu,Daniel P. Rossignol,William J. Christ,Yoshito Kishi +8 more
TL;DR: It is argued that the novel synthetic lipid A analogue E5531 can antagonize the action of L PS in in vitro and suppress the pathological effects of LPS in vivo in mice.
Patent
Quinone derivatives and pharmacological use
Abe Shinya,Yasushi Okamoto,Katsuya Tagami,Shigeki Hibi,Junichi Nagakawa,Kazuo Hirota,Ieharu Hishinuma,Kaname Miyamoto,Takashi Yamanaka,Hiromitsu Yokohama,Tsutomu Yoshimura,Tohru Horie,Yasunori Akita,Koichi Katayama,Isao Yamatsu +14 more
TL;DR: A quinone derivative useful in the treatment of hepatic diseases defined by the general formula: "STR1##" where R1 is selected from the group consisting of alkyl, alkenly, alkynyl or heterocycle, R2 is a substituted nitrogen containing radical wherein the substituents on said nitrogen are selected from a group consisting either of hydrogen, substituted or unsubstituted lower alkyls, and where said nitrogen may be a ring heteroatom, and R3, R4 and R5, may be the same or different and each
Journal ArticleDOI
Suppressive effects of E3330, a novel quinone derivative, on tumor necrosis factor-α generation from monocytes and macrophages
Kaname Miyamoto,Junichi Nagakawa,Ieharu Hishinuma,Kazuo Hirota,Masahiro Yasuda,Takashi Yamanaka,Kouichi Katayama,Isao Yamatsu +7 more
TL;DR: Findings indicate that E3330 has a suppressive effect on TNF-α generation from monocytes/macrophages, regardless of origin or species, and this effect is based in part on the suppression of T NF-α mRNA expression.